Forecasting A Brighter Future For Clinical Trial Supply In Emerging Markets An Interview With Adrian Peskett
Forecasting a Brighter Future for Clinical Trial Supply in Emerging Markets- An Interview with Adrian Peskett
Pharma IQ interviewed Adrian Peskett, Clinical Supply Logistics Director at Pfizer Ltd. about his predictions for the future of clinical trial supply in emerging markets. Adrian also speaks about the importance of forecasting in emerging markets and the difficulties in standardising strategy, while meeting countries' individual needs.
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.
Your experience on this site will be improved by allowing cookies.